信达生物(01801.HK)授出1.5万份购股权

Core Viewpoint - The company announced the granting of stock options and restricted shares to employees as part of its 2024 share plan, indicating a focus on employee incentives and retention [1] Group 1 - The company granted 15,000 stock options to 3 grantees [1] - The company also granted 148,200 restricted shares to 29 grantees [1] - All grantees are non-associated employees of the group, not part of senior management [1]